课题基金 / 基金详情

Multiplexed Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI) of Breast Cancer, Prostate Cancer, and Colorectal Cancer for Proteomic and Metabolomic Biomarker Discovery, Validation, and Verification for the Development of

Multiplexed Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI) of Breast Cancer, Prostate Cancer, and Colorectal Cancer for Proteomic and Metabolomic Biomarker Discovery, Validation, and Verification for the Development of
乳腺癌、前列腺癌和结直肠癌的多重基质辅助激光解吸/电离 (MALDI) 质谱成像 (MSI)，用于蛋白质组学和代谢组学生物标志物的发现、验证和验证，以开发
批准号：
365421
负责人：
Luehr Teesha C
金额：
$7.65万
依托单位：
University of Victoria Genome British Columbia Proteomics Centre (BC)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2019-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365421&lang=en
关键词：
Biomaker Biomaker Discovery Biomaker Verification Breast Cancer Colorectal Diagnosis Mass Spectrometry Prognosis Prostate

项目摘要

项目成果

Luehr Teesha C的其他基金

相似基金

相关文献

中文摘要
翻译
乳腺癌（BC）、前列腺癌（PC）和结直肠癌（CRC）是世界范围内发病率和死亡率最高的三大癌症病因。这一趋势适用于加拿大；2015年女性新诊断病例中分别有25.9%和11.9%为BC a
英文摘要
Breast cancer (BC), prostate cancer (PC), and colorectal cancer (CRC) are three leading causes of cancer in both incidence rates and mortality worldwide. This trend holds true for Canada; in 2015 25.9% and 11.9% of newly diagnosed cases in women were BC a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed tissue imaging of prostate cancer for biomarker discovery and validation
海外基金